Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Redwood City, California
- Most recent report
- 10-Q, filed Jul 29, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1088856
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 45
News 8 of 103
Prospectuses and Registrations 8 of 22
- S-8 Registration statement for an employee plan May 29, 2026
- S-8 POS Post-effective amendment to an employee plan registration May 31, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 31, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 31, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 31, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 31, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 31, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 31, 2024
Proxies 8 of 14
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material Apr 18, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2024
- DEFA14A Extra proxy material May 8, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2023
- PRE 14A Preliminary proxy statement Apr 4, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2022
Ownership 8 of 786
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 3 Insider reported their initial holding Sep 3, 2026
- 144 Notice of a proposed sale of restricted stock Sep 2, 2026
Other 8 of 31
- UPLOAD Comment letter from SEC staff Dec 11, 2025
- CORRESP Reply to SEC staff Oct 1, 2025
- UPLOAD Comment letter from SEC staff Sep 18, 2025
- ARS Annual report sent to shareholders Apr 17, 2024
- UPLOAD Comment letter from SEC staff Aug 24, 2023
- CORRESP Reply to SEC staff Aug 15, 2023
- UPLOAD Comment letter from SEC staff Aug 7, 2023
- ARS Annual report sent to shareholders Apr 14, 2023
Everything here comes from Corcept Therapeutics Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.